Company
Pierrel S.p.A.
Headquarters: Capua, CE, Italy
Employees: 96
CEO: Dr. Fulvio Citaredo
Market Cap
€95.6 Million
EUR as of Jan. 1, 2024
US$105.6 Million
Pierrel S.p.A. Categories
Italy Healthcare Drug Manufacturers—GeneralItaly Healthcare Italy Drug Manufacturers—General
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Pierrel S.p.A. provides contract manufacturing services to the life science, biopharma, and pharmaceutical industries worldwide. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations, as well as develops and manufactures dental anesthetics under the Orabloc brand name. It also engages in the development, registration, and licensing of new drugs and medical devices. Pierrel S.p.A. is based in Capua, Italy.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Pierrel S.p.A. has the following listings and related stock indices.
Stock: MTA: PRL wb_incandescent
Stock: FSX: 2FJ wb_incandescent